🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
25.74
-0.61 (-2.31%)
Nov 20, 2026, 3:04 PM CST

SHE:002294 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
28,48155,23934,48135,64436,22530,220
Market Cap Growth
-57.70%60.20%-3.26%-1.60%19.87%3.71%
Enterprise Value
27,65753,22032,68833,89833,15427,017
Last Close Price
25.7448.7730.0531.1630.9125.23

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
40.2784.7957.3261.4556.8656.62
Forward PE
-75.6551.5558.3254.7527.88
PS Ratio
5.8712.698.5910.5910.409.88
PB Ratio
3.296.103.944.434.543.76
P/TBV Ratio
4.007.564.685.335.244.38
P/FCF Ratio
382.79705.1561.42211.6197.4243.02
P/OCF Ratio
26.4152.4929.0742.4637.3225.50
PEG Ratio
-1.151.151.151.151.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
EV/Sales Ratio
5.7012.238.1510.079.528.83
EV/EBITDA Ratio
23.9751.7331.2437.9537.9533.84
EV/EBIT Ratio
37.7983.1047.8059.9158.6253.57
EV/FCF Ratio
371.71679.3758.22201.2489.1638.46

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Debt / Equity Ratio
0.110.030.020.010.030.01
Debt / EBITDA Ratio
0.800.280.130.070.240.10
Debt / FCF Ratio
12.473.700.240.380.560.11
Net Debt / Equity Ratio
-0.11-0.31-0.31-0.27-0.42-0.40
Net Debt / EBITDA Ratio
-0.83-2.72-2.59-2.40-3.80-4.03
Net Debt / FCF Ratio
-12.74-35.75-4.83-12.70-8.93-4.58
Asset Turnover
0.440.400.400.350.370.38
Inventory Turnover
2.312.102.282.062.082.00
Quick Ratio
1.731.973.093.402.563.88
Current Ratio
2.472.283.624.072.944.35
Return on Equity (ROE)
7.99%7.33%7.20%7.25%7.92%7.75%
Return on Assets (ROA)
4.12%3.68%4.30%3.69%3.72%3.90%
Return on Invested Capital (ROIC)
9.99%10.37%10.95%9.69%10.60%9.13%
Return on Capital Employed (ROCE)
7.60%6.90%7.30%6.60%6.90%6.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Earnings Yield
2.48%1.18%1.75%1.63%1.76%1.77%
FCF Yield
0.26%0.14%1.63%0.47%1.03%2.33%
Dividend Yield
2.14%1.11%1.62%1.53%1.51%1.46%
Payout Ratio
86.45%85.68%90.77%94.71%69.25%2.91%
Buyback Yield / Dilution
0.16%-0.83%0.13%-1.55%-2.90%-5.23%
Total Shareholder Return
2.29%0.28%1.75%-0.02%-1.40%-3.77%